12:00 AM
 | 
Feb 11, 2008
 |  BioCentury  |  Product Development

ACCORD and Steno-2 outcomes

ACCORD and Steno-2 outcomes

ACCORD and Steno-2 outcomes
Glycated hemoglobin and mortality in two trials in patients with Type II diabetes. The mortality rates represent the number of all-cause deaths per 1,000 individuals per...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >